Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
Human Reproduction (Oxford, England)|December 1, 2001
Endometrial cavity fluid is associated with poor ovarian response and increased cancellation rates in ART cyclesA J Levi, J H Segars, B T Miller, et al.American Journal of Obstetrics and Gynecology|August 15, 2000
Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnanciesM P Leondires, S D Ernst, B T Miller, et al.Journal of Assisted Reproduction and Genetics|August 24, 2000
Intracytoplasmic sperm injection increases embryo fragmentation without affecting clinical outcomeJ L Frattarelli, M P Leondires, B T Miller, et al.Fertility and Sterility|December 11, 1999
Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilizationM P Leondires, M Escalpes, J H Segars, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1986
Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male ratT J Cicero, A Aleem, E R Meyer, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|October 22, 2002
Progastrin1-80 stimulates growth of intestinal epithelial cells in vitro via high-affinity binding sitesP Singh, X Lu, S Cobb, et al.Fertility and Sterility|October 10, 2001
Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cyclesA J Levi, M R Drews, P A Bergh, et al.The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Influence of morphine exposure during adolescence on the sexual maturation of male rats and the development of their offspringT J Cicero, M L Adams, A Giordano, et al.Fertility and Sterility|September 26, 2000
Basal antral follicle number and mean ovarian diameter predict cycle cancellation and ovarian responsiveness in assisted reproductive technology cyclesJ L Frattarelli, D F Lauria-Costab, B T Miller, et al.Endocrinology|June 22, 2012
Statins and downstream inhibitors of the isoprenylation pathway increase type 2 iodothyronine deiodinase activityB T Miller, C B Ueta, V Lau, et al.Pageof 6